Bromide

Bromide

SCHEMBL1757103

Cc1cc[n+](Cc2ccccc2)cc1.[Br-]

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CHKA known ✓ P35790 11/20 0.70
ACHE known ✓ P22303 2/20 0.48
ALDH1A1 P00352 3/20 0.72
KDM4E B2RXH2 1/20 0.72
RAB9A P51151 1/20 0.72
LMNA P02545 2/20 0.63
HTT P42858 2/20 0.63
SMN1; SMN2 Q16637 2/20 0.63
BCHE P06276 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824133 0.98 ALDH1A1 (0.75) ALDH1A1KDM4ERAB9ACHKALMNA
Hydrochloric Acid SCHEMBL3278043 0.96 ALDH1A1 (0.79) ALDH1A1KDM4ERAB9ACHKALMNA
SCHEMBL15164180 0.86 CHKA (0.83) ALDH1A1KDM4ERAB9ACHKALMNA
Bromide SCHEMBL11693463 0.83 CHKA (0.63) ALDH1A1KDM4ERAB9ACHKALMNA
Benzyl Viologen SCHEMBL4079047 0.82 ALDH1A1 (0.71) ALDH1A1KDM4ERAB9ACHKALMNA
Bromide SCHEMBL28611338 0.81 CHKA (0.61) ALDH1A1KDM4ERAB9ACHKALMNA
Bromide SCHEMBL365151 0.81 CHKA (0.61) ALDH1A1KDM4ERAB9ACHKALMNA
SCHEMBL13283227 0.81 CHKA (0.61) ALDH1A1KDM4ERAB9ACHKALMNA
Bromide SCHEMBL8857808 0.81 CHKA (0.57) ALDH1A1KDM4ERAB9ACHKALMNA
SCHEMBL367939 0.80 ALDH1A1 (0.63) ALDH1A1KDM4ERAB9ACHKALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2982245-B1 CYANINE DYES FOR LABELING OF TARGET MOLECULES, IDENTIFICATION OF ORGANELLES AND OTHER APPLICATIONS ENZO LIFE SCIENCES INC (US) 2018-08-08 EP disclosed
EP-1885718-B1 FLUORESCENT CHEMICAL COMPOUNDS HAVING HIGH SELECTIVITY FOR DOUBLE STRANDED DNA, AND METHODS FOR THEIR USE LIFE TECHNOLOGIES CORP (US) 2017-03-15 EP disclosed
US-9366676-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2016-06-14 US disclosed
EP-2982245-A1 LABELING OF TARGET MOLECULES, IDENTIFICATION OF ORGANELLES AND OTHER APPLICATIONS, NOVEL COMPOSITIONS, METHODS AND KITS Enzo Life Sciences, Inc. (US) 2016-02-10 EP disclosed
US-20150316558-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use MOLECULAR PROBES, INC. 2015-11-05 US disclosed
EP-2381783-B1 LABELING OF TARGET MOLECULES, IDENTIFICATION OF ORGANELLES AND OTHER APPLICATIONS, NOVEL COMPOSITIONS, METHODS AND KITS ENZO LIFE SCIENCES INC (US) 2015-09-02 EP disclosed
US-9115397-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2015-08-25 US disclosed
US-20150004597-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use LIFE TECHNOLOGIES CORP (US) 2015-01-01 US disclosed
US-8865904-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2014-10-21 US disclosed
US-8674102-B2 Fluorescent dyes ENZO LIFE SCIENCES, INC. (US) 2014-03-18 US disclosed
WO-2010065918-A1 LABELING OF TARGET MOLECULES, IDENTIFICATION OF ORGANELLES AND OTHER APPLICATIONS, NOVEL COMPOSITIONS, METHODS AND KITS ENZO LIFE SCIENCES, INC. (US) 2010-06-10 WO disclosed
US-7598390-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2009-10-06 US disclosed
US-20090226954-A1 Labeling of target molecules, identification of organelles and other applications, novel compositions, methods and kits ENZO LIFE SCIENCES, INC. 2009-09-10 US disclosed
EP-1885718-A1 FLUORESCENT CHEMICAL COMPOUNDS HAVING HIGH SELECTIVITY FOR DOUBLE STRANDED DNA, AND METHODS FOR THEIR USE Molecular Probes, Inc. (US) 2008-02-13 EP disclosed
WO-2006124816-A1 FLUORESCENT CHEMICAL COMPOUNDS HAVING HIGH SELECTIVITY FOR DOUBLE STRANDED DNA, AND METHODS FOR THEIR USE MOLECULAR PROBES, INC. (US) 2006-11-23 WO disclosed
US-20060263844-A1 Flourescent chemical compounds having high selectivity for double standard DNA, and methods for their use MOLECULAR PROBES, INC. 2006-11-23 US disclosed
EP-1015433-B1 SUBSTITUTED 1,2,3,4,5,6-HEXAHYDRO-2,6-METHANO-3-BENZAZOCINE-10-OLES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2004-05-26 EP disclosed
US-6455538-B1 SODIUM CHANNEL MODULATORS; BRAIN AND NERVOUS SYSTEM DISORDERS BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-09-24 US disclosed
EP-1015433-A1 SUBSTITUTED 1,2,3,4,5,6-HEXAHYDRO-2,6-METHANO-3-BENZAZOCINE-10-OLES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim Pharma KG (DE) 2000-07-05 EP disclosed
WO-1999014199-A1 SUBSTITUTED 1,2,3,4,5,6-HEXAHYDRO-2,6-METHANO-3-BENZAZOCINE-10-OLES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090226954-A1 Labeling of target molecules, identification of organelles and other applications, novel compositions, methods and kits SSBP1, IMMT, DNAJA3 CHKA 1419/4885ACHE 4522/4885ALDH1A1 4074/4885
US-20150316558-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use POLRMT, DNA2, NSUN2 CHKA 2846/4885ACHE 4710/4885ALDH1A1 2461/4885
US-20150004597-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use POLRMT, DNA2, NSUN2 CHKA 2846/4885ACHE 4710/4885ALDH1A1 2461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.